Skip to the page

Data / Form D filings / Bioptigen Inc

Bioptigen Inc: Form D filing

Bioptigen Inc, a health care company in Durham, NC, filed a Form D with the SEC in 2011. The latest, on March 3, 2011, reports $1.5 million sold of a $1.5 million offering to 1 investor.

Find out what Bioptigen Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
104 TW ALEXANDER DRIVE, BUILDING #2, Durham, NC, 27709
Phone
(919) 314-5500
Industry
Other Health Care
Entity type
Corporation
Incorporated in
North Carolina
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506
SEC identifier (CIK)
1329142

The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 3, 2011New notice$1,500,000$1,500,000$01Feb 28, 2011sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Eric L. BucklandExecutive Officer, Director
Thomas D LivingstonExecutive Officer

Other health care companies in North Carolina that filed recently

Every Form D from the week of Feb 28, 2011 · All recent filings in North Carolina · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Bioptigen Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.